Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer, Secondary cancers
Closed
Phase 3
This trial is comparing 2 combinations of treatment for cancer of the food pipe (oesophagus) that has spread to another part of the body.
One combination of treatment is chemotherapy and pembrolizumab. The other combination is chemotherapy, pembrolizumab and lenvatinib.
Recruitment start: 1 March 2022
Recruitment end: 31 January 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Wasat Mansoor
Merck Sharp & Dohme Ltd
Last reviewed: 12 February 2025
CRUK internal database number: 18721
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
